Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Biotechnology
(
Latest Titles
)
-
Genomics
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
A Guide to Viral Clearance-Strategies for Biopharmaceutical Safety
static version
printer friendly
pdf version
Advances in Industrial Enzymes--A Global Technology Assessment
static version
printer friendly
pdf version
Applications of Pharmacogenomics
static version
printer friendly
pdf version
Asymmetric Synthesis: The Essentials, Second, Completely Revised Edition
static version
printer friendly
pdf version
^ Top
B
Bioinformatics - From Genomes to Therapies
static version
printer friendly
pdf version
Biomed Outsourcing Report: Biopathways, New Targets, New Opportunities in Discovery Research
static version
printer friendly
pdf version
Bioregenerative Engineering: Principles and Applications
static version
printer friendly
pdf version
Blockbusters of the Future: Is the search for new blockbusters a sustainable growth model?
static version
printer friendly
pdf version
^ Top
C
Cancer genomics: The impact of genomic advances in oncology
static version
printer friendly
pdf version
Chemical and Functional Genomic Approaches to Stem Cell Biology and Regenerative Medicine
static version
printer friendly
pdf version
Chemical Genomics - Commercial Applications in Drug Discovery and Development
static version
printer friendly
pdf version
Concepts in Genetic Medicine
static version
printer friendly
pdf version
Cortical Development: Genes and Genetic Abnormalities
static version
printer friendly
pdf version
CuraGen Corporation - SWOT Framework Analysis
static version
printer friendly
pdf version
^ Top
D
Developments in Pharmacogenomics (Technical Insights)
static version
printer friendly
pdf version
Dictionary of DNA and Genome Technology
static version
printer friendly
pdf version
DNA Paternity Testing Centers in China and Hong Kong
static version
printer friendly
pdf version
DNA Sequencing 2008
static version
printer friendly
pdf version
DNA/RNA Therapies: Translating The Genome Into A $1.2bn Market By 2010
static version
printer friendly
pdf version
Drug Discovery Research: New Frontiers in the Post-Genomic Era
static version
printer friendly
pdf version
Drugs in the Pipeline--An R&D Analysis
static version
printer friendly
pdf version
^ Top
E
Emerging Developments in Gene Therapy and DNA Vaccines
static version
printer friendly
pdf version
Emerging Generic Drug Markets in Europe
static version
printer friendly
pdf version
Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies
static version
printer friendly
pdf version
Environmental Microbiology: From Genomes to Biogeochemistry
static version
printer friendly
pdf version
Epigenetics: Principles of Eukaryotic Genome Control
static version
printer friendly
pdf version
Ethics, Law and Society 2007
static version
printer friendly
pdf version
External Sources of Tissue Microarrays
static version
printer friendly
pdf version
^ Top
F
Financial Modelling and Evaluation of Transgenic Manufacturing
static version
printer friendly
pdf version
From Genes to Genomes: Concepts and Applications of DNA Technology, 2nd Edition
static version
printer friendly
pdf version
^ Top
G
Gene Therapy-Industry Impact
static version
printer friendly
pdf version
Gene Therapy: It’s Finally Starting to Work! Immediate Opportunities and Future Implications
static version
printer friendly
pdf version
Genomics and Genetics: From Molecular Details to Analysis and Techniques
static version
printer friendly
pdf version
Genomics and Proteomics Markets in Australia
static version
printer friendly
pdf version
Genomics Players: From Discovery to Integration- Business and Technology Assessment, 2002
static version
printer friendly
pdf version
Genomics World Markets 2008
static version
printer friendly
pdf version
Genomics: Pharmaceutical Investment, Integration and Partnerships
static version
printer friendly
pdf version
Global Market for Functional Genomics, 2000-2010
static version
printer friendly
pdf version
Global Market for SNP Genotyping, 2000-2011
static version
printer friendly
pdf version
Gpcrs: The Targets of Today's Drugs and Tomorrow's Blockbusters
static version
printer friendly
pdf version
^ Top
H
Has Genomics Failed to Deliver?
static version
printer friendly
pdf version
Hepatitis C virus (HCV) - Future HCV Drug Discovery Technologies
static version
printer friendly
pdf version
Hepatotoxicity: From Genomics to In Vitro and In Vivo Models
static version
printer friendly
pdf version
How to Get Ahead with Pharmacogenomics
static version
printer friendly
pdf version
^ Top
I
Introduction to Soft Matter: Synthetic and Biological Self-Assembling Materials, Revised Edition
static version
printer friendly
pdf version
Ion Channels as Therapeutic Targets for Multiple Diseases
static version
printer friendly
pdf version
^ Top
M
Market Dynamics 2002: Anti-Cancer Innovatives Series Part III - Gene Therapies
static version
printer friendly
pdf version
Maximizing R&D Productivity: Getting More Bang For Your R&D Buck
static version
printer friendly
pdf version
Microbial Genotyping: Applications for DNA Microarrays
static version
printer friendly
pdf version
Microbial Genotyping: Areas of Research
static version
printer friendly
pdf version
Microbial Genotyping: Diagnostic and Testing Assay
static version
printer friendly
pdf version
Microbial Genotyping: Molecular Genotyping Techniques
static version
printer friendly
pdf version
Microbial Genotyping: Primary Source for DNA Microarrays
static version
printer friendly
pdf version
Molecular Nutrition and Genomics: Nutrition and the Evolution of Humankind
static version
printer friendly
pdf version
^ Top
N
Next Generation Sequencing for Life Science R&D: Advancing to the $1,000 Genome.
static version
printer friendly
pdf version
Next-Generation Genomic Sequencing: Market Evaluation
static version
printer friendly
pdf version
^ Top
O
Opportunities in Genomics and Associated High-Throughput Screening Markets
static version
printer friendly
pdf version
Opportunities in the U.S. Neurogenomics Markets
static version
printer friendly
pdf version
^ Top
P
Partnering and business trends in transgenic manufacturing
static version
printer friendly
pdf version
Personalized Medicine: The Impact of Pharmacogenomics on Pharmaceutical R&D and Sales
static version
printer friendly
pdf version
PharmaVitae 2001: Celera Genomics
static version
printer friendly
pdf version
PharmaVitae 2001: Genentech Inc.
static version
printer friendly
pdf version
PharmaVitae 2001: Genset
static version
printer friendly
pdf version
PharmaVitae 2001: Genzyme
static version
printer friendly
pdf version
PharmaVitae 2001: Human Genome Sciences
static version
printer friendly
pdf version
PharmaVitae 2001: Qiagen
static version
printer friendly
pdf version
PharmaVitae 2002: Genentech
static version
printer friendly
pdf version
Plant Biotechnology and Genetics: Principles, Techniques and Applications
static version
printer friendly
pdf version
Post Genome Project Era Proteomics R&D Competition
static version
printer friendly
pdf version
Proteomics and Bioethics: The Future of the Human Genome
static version
printer friendly
pdf version
^ Top
R
Revenue Structure and Contract Models for Transgenic Manufacturing and Antibody Licencing
static version
printer friendly
pdf version
RNA Interference Markets
static version
printer friendly
pdf version
RNAi Therapeutics 2008 Market Report
static version
printer friendly
pdf version
^ Top
S
Seattle Genetics, Inc:Premium Company Profile
static version
printer friendly
pdf version
Stem Cell Research 2008
static version
printer friendly
pdf version
Stem Cells 2007-2008 Market Report
static version
printer friendly
pdf version
Strategic Analysis of Thermal Cycler Markets in Europe
static version
printer friendly
pdf version
Strategic Analysis of U.S. Genomics Markets
static version
printer friendly
pdf version
Strategic Analysis of World DNA Microarray Markets
static version
printer friendly
pdf version
Strategic Perspectives 2001: Cardiovascular Gene Therapy - Injecting New Life Into Mature Markets
static version
printer friendly
pdf version
^ Top
T
Telecommunication Equipment Market 2007-2010
static version
printer friendly
pdf version
Testicular Chromosome Structure and Gene Expression
static version
printer friendly
pdf version
The Competitive Landscape of Cancer Gene Therapy
static version
printer friendly
pdf version
The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009
static version
printer friendly
pdf version
The Genomics Outlook To 2005: Transforming Pharmaceutical And Diagnostic Markets
static version
printer friendly
pdf version
The Virtual Genome: From Genes to Drugs Via the Internet
static version
printer friendly
pdf version
Toxicogenomics: Data Analysis Software Usage
static version
printer friendly
pdf version
Toxicogenomics: Databases Used in Toxicogenomics Research
static version
printer friendly
pdf version
Toxicogenomics: DNA Microarrays
static version
printer friendly
pdf version
Toxicogenomics: Primary Research Goals
static version
printer friendly
pdf version
Transcription Factor: A Practical Approach
static version
printer friendly
pdf version
Transforming Drug Discovery through Genomics and Proteomics
static version
printer friendly
pdf version
Transgenic manufacturing the whole analysis
static version
printer friendly
pdf version
^ Top
U
U.S. DNA Microarray Markets
static version
printer friendly
pdf version
U.S. DNA Sequencing Technology Markets
static version
printer friendly
pdf version
U.S. DNA-Based Diagnostic and Test Market
static version
printer friendly
pdf version
U.S. Gene Therapy Markets
static version
printer friendly
pdf version
U.S. Genetic Diagnostics Markets
static version
printer friendly
pdf version
U.S. Genetic Testing Markets
static version
printer friendly
pdf version
U.S. Growth Factors Markets
static version
printer friendly
pdf version
U.S. Pharmacogenomics Markets
static version
printer friendly
pdf version
U.S. Sequencing Services Markets
static version
printer friendly
pdf version
U.S., European, and Japanese Growth Hormone Markets
static version
printer friendly
pdf version
Understanding Genomics and Global Health Impacts
static version
printer friendly
pdf version
^ Top
V
Visualizing Human Biology
static version
printer friendly
pdf version
^ Top
W
World Cancer Assay Markets
static version
printer friendly
pdf version
World Gene Therapy Market
static version
printer friendly
pdf version
All rights reserved. © copyright 2006 Research and Markets
Terms and conditions
Privacy Policy